Acetaminophen

Scientists have discovered a way to turn plastic waste into acetaminophen. (luchschenF/Shutterstock)

In a nutshell

  • Researchers discovered that acetaminophen (Tylenol) relieves pain by blocking specific sodium channels in peripheral nerves, not by acting in the brain as long believed.
  • The key player is AM404, a compound your body creates from acetaminophen, which selectively shuts down pain-sensing neurons without affecting other nerve functions.
  • This new understanding could pave the way for safer, more targeted pain treatments that avoid the side effects of traditional anesthetics.

JERUSALEM — Most home medicine cabinets are equipped with acetaminophen for headache and fever relief and have been for nearly a century. Yet despite being one of the most widely used pain relievers on the planet, scientists have had trouble figuring out how it actually works. Now, new research from the Hebrew University of Jerusalem reveals that the drug’s pain-killing power comes from blocking specific nerve channels in our extremities, not from affecting our brain as previously believed.

Research published in the Proceedings of the National Academy of Sciences shows that acetaminophen doesn’t work primarily in the central nervous system as long assumed. Instead, its active form targets pain-sensing nerve channels in our hands, feet, and other peripheral areas, acting like a highly selective local anesthetic that only affects pain nerves.

Tylenol is a brand name of acetaminophen. When you pop a Tylenol, your liver breaks it down into a compound called 4-aminophenol, which travels through your bloodstream to reach tissues throughout your body. Once there, an enzyme called FAAH transforms it into a molecule named AM404, which is what fights pain.

Previous studies had focused on AM404’s effects in the brain and spinal cord, where scientists thought it worked by activating cannabinoid and heat-sensing receptors. But the Hebrew University team discovered that sensory neurons in our peripheral nervous system, the network of nerves outside our brain and spinal cord, can also produce AM404 locally.

Tylenol, acetaminophen
Tylenol contains acetaminophen. (© RadosÅ‚aw Brzozo – stock.adobe.com)

The researchers designed experiments to test whether this peripheral production of AM404 could explain acetaminophen’s pain-relieving effects. Using isolated nerve cells from rats, they exposed trigeminal ganglia (nerve clusters near the jaw) to 4-aminophenol and measured AM404 production. The nerve cells made more AM404 when they were exposed to higher amounts of 4-aminophenol.

Blocking Pain at the Source

Researchers then tested how AM404 affects nerve firing. When they applied AM404 to pain-sensing neurons, the compound completely shut down the neurons’ ability to fire action potentials, the electrical signals that carry pain messages to the brain.

AM404 accomplished this at incredibly low concentrations. Researchers found that nanomolar amounts (billionths of a gram per liter) were sufficient to block nerve firing. For context, that’s roughly equivalent to dissolving a single grain of salt in an Olympic-sized swimming pool.

AM404 didn’t randomly shut down all nerve activity. It specifically targeted two types of sodium channels called NaV1.7 and NaV1.8, which are found almost exclusively on pain-sensing neurons. These channels allow sodium ions to rush into nerve cells, triggering the electrical signals we perceive as pain.

To prove their findings worked beyond isolated cells, the research team injected AM404 directly into rat paws and measured their responses to painful stimuli. Rats treated with AM404 showed significantly higher pain thresholds. They could tolerate more intense heat and mechanical pressure before showing signs of discomfort.

Only the treated paw showed increased pain tolerance, while the untreated paw remained normally sensitive. This strongly supported the idea that AM404 works peripherally rather than systemically through the brain.

Researchers tested AM404 on both short-term and long-lasting types of pain. They used specific injections to create temporary and chronic inflammation in rats. In both cases, applying AM404 directly to the area noticeably reduced the animals’ pain responses.

How AM404 Actually Works

Results showed that AM404 binds to the same site on sodium channels that local anesthetics like lidocaine use, but with a crucial difference. While traditional local anesthetics block all types of sodium channels indiscriminately (which is why your entire mouth goes numb at the dentist), AM404 shows a strong preference for the pain-specific channels NaV1.7 and NaV1.8. When researchers altered the specific spot where local anesthetics attach to these channels, AM404’s pain-blocking effects disappeared entirely.

This selectivity could explain why acetaminophen provides pain relief without causing the widespread numbness associated with local anesthetics. It’s like having a key that only opens certain doors in a building, rather than a master key that opens everything.

Researchers also discovered that AM404 exhibits sophisticated blocking behavior similar to traditional local anesthetics. This means the compound becomes more effective at blocking channels that are actively firing, making it particularly good at silencing overactive pain signals while leaving normal nerve function relatively undisturbed.

Common OTC painkillers and pain medicine
Acetaminophen blocks pain at the source instead of in the brain. (© ColleenMichaels – stock.adobe.com)

When they tested other substances that the body creates when breaking down acetaminophen, including acetaminophen itself and other byproducts, none of them could block pain the way AM404 does. This proves that AM404 is really the star of the show when it comes to why Tylenol actually works.

Researchers suggest that AM404 itself could be developed as a new type of pain medication, one that specifically targets pain nerves without affecting other types of sensation or motor function.

Current local anesthetics work well but block all nerve signals in an area, causing complete numbness, and their effects are relatively short-lived. A compound like AM404 could potentially provide targeted relief for chronic pain conditions without these drawbacks. AM404’s effects on other sodium channels, including those in the heart, would need careful evaluation before any clinical applications.

After 75 years of mystery, we finally understand that acetaminophen’s pain-relieving effects don’t come from dulling our brain’s perception of pain, but from silencing the pain signals at their source. No wonder it’s so effective.

Paper Summary

Methodology

Researchers from Hebrew University used multiple experimental approaches to investigate how acetaminophen’s metabolite AM404 produces pain relief. They isolated nerve cells from rat trigeminal and dorsal root ganglia, exposed them to AM404, and measured electrical activity using patch-clamp electrophysiology. They also expressed human sodium channel proteins in cell lines to test AM404’s effects on specific channel types. For behavioral studies, they injected AM404 into rat paws and measured responses to thermal and mechanical pain stimuli using established protocols like the Hargreaves test and von Frey filaments. The team used both male and female rats and found no significant sex differences in responses.

Results

AM404 completely blocked action potential firing in pain-sensing neurons at nanomolar concentrations, with IC50 values around 4-8 nM. The compound specifically inhibited sodium channels NaV1.7 and NaV1.8 through the local anesthetic binding site, showing use-dependent and state-dependent blocking properties. Local injection of AM404 significantly increased pain thresholds in both acute and inflammatory pain models, with effects lasting about one hour. Importantly, AM404 showed selectivity for pain-specific channels over other sodium channel types, and its effects were localized to the injection site rather than systemic.

Limitations

The study was conducted primarily in rats, so human relevance requires further validation. Researchers used relatively high concentrations of AM404 (10 mM) for behavioral studies to simulate local anesthetic dosing, which may not reflect physiological concentrations achieved through oral acetaminophen administration. The study focused on peripheral mechanisms and didn’t fully explore potential central nervous system contributions. Long-term safety and potential effects on cardiac sodium channels (NaV1.5) would need careful evaluation for any therapeutic applications.

Funding and Disclosures

This research was funded by multiple Israeli grants including the Israel Science Foundation (grants 2136/20, 1470/17, and 1202/23), the Israel Cancer Research Fund, and the Deutsch-Israelische Projectkooperation program. The authors declared no competing interests. The work was also supported by endowed chairs including the Cecile and Seymour Alpert Chair in Pain Research and the Jacob Gitlin Chair in Physiology.

Publication Information

This study, “The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels,” was published in the Proceedings of the National Academy of Sciences (PNAS) on June 4, 2025 (Volume 122, Number 23). The research was conducted by Yossef Maatuf, Yishai Kushnir, Alina Nemirovski, Mariana Ghantous, Ariel Iskimov, Alexander M. Binshtok, and Avi Priel from the Hebrew University of Jerusalem’s Institute for Drug Research, Department of Medical Neurobiology, and Edmond and Lily Safra Center for Brain Sciences.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment